CMS Announces Significant Rate Increase for Medicare Advantage Plans
The Centers for Medicare & Medicaid Services (CMS) announced a significant 2.48% average rate increase for Medicare Advantage (MA) plans for 2027, a notable adjustment from the initially proposed 0.09% increase. This revision is projected to infuse over $13 billion in additional payments to MA plans, starkly differing from the originally intended $700 million. The increase highlights the substantial impact of the risk adjustment process, which assesses reimbursement based on enrollee demographics and medical conditions.
CMS initially recommended updates to the risk adjustment model, suggesting the inclusion of more recent diagnostic and spending data to refine payment accuracy. However, these proposed revisions were excluded in the final rule, attributing to the higher rate update. Chris Klomp, Medicare Director, clarified that while the risk adjustment model wasn't entirely dismissed, insurers did not secure their target rates beyond 2.48%.
The finalized regulations provide financial relief for insurers like UnitedHealthcare and Humana, who have been grappling with high medical expenses. The announcement triggered a notable rise in the stock prices of these providers. Jefferies analyst David Windley underscored the considerable relief these finalized rates deliver to the insurance sector.
Initially confronting an unexpected proposal of minimal rate increases in January, insurers launched a lobbying campaign to secure a more favorable outcome. This campaign involved sponsoring research, advertising, engaging policymakers, and expressing critiques, ultimately resulting in a more favorable rate adjustment than initially anticipated.
The CMS's finalized regulations include measures to prevent payments for diagnoses unrelated to direct patient encounters, except for insurers conducting chart reviews to assess conditions of new members. However, the recalibration of the risk model, a concern for many in the industry, was ultimately not implemented.
Additionally, a separate regulation from the Trump administration provides nearly $19 billion in support for MA plans over the next decade. Analysts suspect that electoral considerations might have played a role in the decision to overlook changes to the risk model, aligning with fears that minimal rate updates could disrupt senior coverage.
The Better Medicare Alliance commended the outcome, attributing it to advocacy by numerous stakeholders advocating for comprehensive funding for Medicare Advantage. Without satisfactory rates, there was a risk of reduced benefits and plan exits that would affect 35 million seniors enrolled in MA plans. To prevent market instability, CMS plans to enhance MA plan audits, address review backlogs, and expand its medical coding workforce, ensuring effective oversight and regulatory compliance.